FDA authorizes new guidance on Pfizer vaccines and boosters for children and adults 

On Jan. 3, 2022, the Food and Drug Administration (FDA) amended the authorization of emergency use of the Pfizer-BioNTech COVID-19 vaccine guidance in three ways.

FDA, CDC and Western States recommend additional vaccine dose for immunocompromised individuals

The U.S. Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC) and Western States Scientific Safety Review Workgroup have all recommended an additional dose of mRNA COVID-19 vaccine be administered to people with moderately to severely compromised immune systems. On Aug. 12, the U.S. Food and Drug Administration (FDA) adjusted the existing […]